I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Sevigny, Jeffrey
45
results:
Online X
Search for persons
X
Format
Online (45)
Mediatypes
Articles (Online) (25)
Bookchapter (Online) (2)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Progranulin AAV gene therapy for frontotemporal dementia: t..:
Sevigny, Jeffrey
;
Uspenskaya, Olga
;
Heckman, Laura Dean
...
Nature Medicine. 30 (2024) 5 - p. 1406-1415 , 2024
Link:
https://doi.org/10.1038/..
?
2
Phase 1/2 study update of an AAV9-based gene therapy for Ga..:
Neuhaus, Sarah
;
Lewis, Travis B.
;
Tamburri, Paul A.
...
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107238 , 2023
Link:
https://doi.org/10.1016/..
?
3
Design and outcome measures for a phase 1/2 dose-finding st..:
Neuhaus, Sarah
;
Tamburri, Paul A.
;
Weaver, Michael A.
...
Molecular Genetics and Metabolism. 138 (2023) 2 - p. 107239 , 2023
Link:
https://doi.org/10.1016/..
?
4
Gene Therapy for Parkinson's Disease Associated with GBA1 M..:
Abeliovich, Asa
;
Hefti, Franz
;
Sevigny, Jeffrey
...
Journal of Parkinson's Disease. 11 (2021) s2 - p. S183-S188 , 2021
Link:
https://doi.org/10.3233/..
?
5
Design of a Phase 1/2 study of an AAV9‐based gene therapy f..:
Uspenskaya‐Cadoz, Olga
;
Benoit, Jamie
;
Mahoney, Erin
...
Alzheimer's & Dementia. 16 (2020) S9 - p. , 2020
Link:
https://doi.org/10.1002/..
?
6
Design of Phase 1/2a Study of AAV9-Based Gene Therapy for P..:
Uspenskaya, Olga
;
Mahoney, Erin
;
Verselis, Lynne
...
Neurology. 94 (2020) 15_supplement - p. , 2020
Link:
https://doi.org/10.1212/..
?
7
S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG72..:
Umbricht, Daniel
;
Dukart, Jürgen
;
Abt, Markus
...
Schizophrenia Bulletin. 44 (2018) suppl_1 - p. S340-S341 , 2018
Link:
https://doi.org/10.1093/..
?
8
Combination therapy for Alzheimer's disease: Are we ready?:
Salloway, Stephen
;
Sevigny, Jeffrey
;
Bain, Lisa J.
..
Alzheimer's & Dementia. 14 (2018) 9 - p. 1232-1233 , 2018
Link:
https://doi.org/10.1016/..
?
9
Current state of Alzheimer's fluid biomarkers:
Molinuevo, José Luis
;
Ayton, Scott
;
Batrla, Richard
...
Acta Neuropathologica. 136 (2018) 6 - p. 821-853 , 2018
Link:
https://doi.org/10.1007/..
?
10
Motor, cognitive, and functional declines contribute to a s..:
Schobel, Scott A.
;
Palermo, Giuseppe
;
Auinger, Peggy
...
Neurology. 89 (2017) 24 - p. 2495-2502 , 2017
Link:
https://doi.org/10.1212/..
?
11
Randomized, Double-Blind, Placebo-Controlled Studies to Eva..:
Viglietta, Vissia
;
O'Gorman, John
;
Williams, Leslie
...
Neurology. 86 (2016) 16_supplement - p. , 2016
Link:
https://doi.org/10.1212/..
?
12
P1–359: A single ascending‐dose study of BIIB037 in people ..:
Sevigny, Jeffrey
;
Williams, Leslie
;
Ferrero, Jim
...
Alzheimer's & Dementia. 9 (2013) 4S_Part_7 - p. , 2013
Link:
https://doi.org/10.1016/..
?
13
P3‐275: Optimization of the treatment regimen with active A..:
Graf, Ana
;
Andreasen, Niels
;
Riviere, M.E.
...
Alzheimer's & Dementia. 6 (2010) 4S_Part_17 - p. , 2010
Link:
https://doi.org/10.1016/..
?
14
Review: Item Analysis of ADAS-Cog: Effect of Baseline Cogni..:
Sevigny, Jeffrey J.
;
Yahong Peng
;
Lian Liu
.
American Journal of Alzheimer's Disease & Other Dementiasr. 25 (2009) 2 - p. 119-124 , 2009
Link:
https://doi.org/10.1177/..
?
15
Early risk assessment for Alzheimer's disease:
Carrillo, Maria C.
;
Blackwell, Andrew
;
Hampel, Harald
...
Alzheimer's & Dementia. 5 (2009) 2 - p. 182-196 , 2009
Link:
https://doi.org/10.1016/..
1-15